Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.
 

Notice of Funding Opportunities

Title Announcement Number Activity Code Clinical Trials Status Expiration Date Program Official
Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech NOT-NS-23-002 06/21/2024
Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers NOT-CA-23-004 07/02/2025 Matthew Young, Ph.D.
Notice of Special Interest (NOSI): Basic Mechanisms of Cannabis and Cannabinoid Action in Cancer NOT-CA-22-085 05/08/2027 Sharon Ross, Ph.D., M.P.H.
Notice of Special Interest (NOSI): Career Development Opportunities for Research Within the Mission of the Division of Cancer Prevention at the National Cancer Institute NOT-CA-23-035 11/13/2024 Jessica Faupel-Badger, Ph.D., M.P.H.
Notice of Special Interest (NOSI): Research on the Etiology, Early Detection, Screening and Prevention of Early-Onset Colorectal Cancer NOT-CA-23-018 09/08/2024 Gary Della'Zanna, D.O., M.Sc.
Cancer Prevention and Control Clinical Trials Planning Grant Program PAR-22-173 (R34 Clinical Trials Optional) R34 05/08/2025 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Cancer Prevention and Control Clinical Trials Planning Grant Program PAR-22-174 (U34 Clinical Trials Optional) U34 05/08/2025 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Notice of Special Interest: Administrative Supplements to Support Collection of Spanish Normative Data and Determination of Test-Retest Reliability Estimates of Neuropsychological Tests for NCI Clinical Trials NOT-CA-24-040 06/22/2024 Cecilia Lee, Dr.P.H., R.N.
Notice of Special Interest (NOSI): Administrative Supplement to Support the NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Research NOT-CA-24-047 06/14/2024 Vignesh Gunasekharan, Ph.D.
Discovery and Development of Natural Products for Cancer Interception and Prevention RFA-CA-23-028 (UG3/UH3 Clinical Trial Not Allowed) UH3, UG3 Clinical Trial Not Allowed 06/14/2025 Altaf Mohammed, Ph.D.